References
- 1. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup; Dellinger, RP; Levy, MM; Rhodes, A et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Critical Care Medicine. 2013;41:580-637.
- 2. Russel, JA. The current management of septic shock. Minerva Medica. 2008;99:431-58.
- 3. Deutschman, CS; Tracey, KJ. Sepsis: Current dogma andnewperspectives. Immunity. 2014;40:463-75.
- 4. Jui J. Septic Shock. In Tintinalli JE, Stapczynski JS, Ma OJ et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide (7th ed.). New York: McGraw-Hill. 2011;pp.1003-14.
- 5. Dellinger RH, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Crit Care Med. 2013;41:580-637.
- 6. Bone R, Balk R, Cerra F, et al. Definitions for sepsisand organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
- 7. Pappa CA, Tsirakis G, Samiotakis P, et al. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Invest. 2013;31:385-9.
- 8. Li C, Sun CJ, Fan JC, et al. “Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma. Med Oncol. 2013;30:571.
- 9. Shroff RC, Price KL, Kolatsi-Joannou M, et al. Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS ONE. 2013;8:e56273.
- 10. Jeansson M, Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest. 2011;121:2278-89.
- 11. Buddingh KT, Koudstaal LG, van Santvoort HC, et al. Early angiopoietin-2 levels after onset predict the advent of severe pancreatitis, multiple organ failure, and infectious complications in patients with acute pancreatitis. J Am Coll Surg. 2014;218:26-32.
- 12. Wang K, Bhandari V, Giuliano JS Jr, O Hern CS, Shattuck MD, Kirby M. Angiopoietin-1, angiopoietin-2 and bicarbonate as diagnostic biomarkers in children with severe sepsis. PLoS One. 2014;25:e108461.
- 13. Mearelli F, Fiotti N, Altamura N, et al. Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study. Intern Emerg Med. 2014;9:749-57.
- 14. Giuliano JS Jr, Tran K, Li FY, Shabanova V, Tala JA, Bhandari V. The temporal kinetics of circulating angiopoietin levels in children with sepsis. Pediatr Crit Care Med. 2014;15:e1-8.
- 15. Gores KM, Delsing AS, Kraus SJ, et al. Plasma Angiopoietin-2 concentrations are related to impaired lung function and organ failure in a clinical cohort receiving high-dose interleukin 2 therapy. Shock. 2014;42:115-20.
- 16. Ziegler T, Horstkotte J, Schwab C, et al. Angiopoietin-2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest. 2013. pii: 66549.
- 17. Tsai YC, Chiu YW, Tsai JC, et al. Association of angiopoietin-2 with renal outcome in chronic kidney disease. PLoS One. 2014;3;9:e108862.
- 18. Felt M, Luck R, Schering A, et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest. 2012;122:1991-2005